Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalini Sethi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Pineal Research|March 18, 2008
C-terminal domains within human MT1 and MT2 melatonin receptors are involved in internalization processesShalini Sethi, Wendy Adams, John Pollock, et al.
Gynecologic Oncology Reports|April 20, 2023
Role for immunotherapy in pretreated, recurrent, metastatic squamous cell carcinoma arising from mature cystic teratomaCarson C Edwards, Steven Blaine Holloway, Shalini Sethi, et al.
Journal of Medicinal Chemistry|February 6, 2009
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonistsDarius P Zlotos, Mohamed I Attia, Justin Julius, et al.
Clinical Obstetrics and Gynecology|December 18, 2024
Placental InfectionsPoonam Khullar, Jane Date Hon, Shalini Sethi, et al.
Bioorganic & Medicinal Chemistry|May 29, 2009
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligandsChristian Markl, Mohamed I Attia, Justin Julius, et al.
Archiv Der Pharmazie|September 3, 2011
N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivityChristian Markl, William P Clafshenkel, Mohamed I Attia, et al.
Journal of Pineal Research|July 15, 2010
Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathwaysShalini Sethi, Nicholas M Radio, Mary P Kotlarczyk, et al.
Frontiers in Oncology|July 30, 2019
Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast CancerBalasunder R Dodda, Corry D Bondi, Mahmud Hasan, et al.
Journal of Pineal Research|May 30, 2012
Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female micePaula A Witt-Enderby, John P Slater, Nakpangi A Johnson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Pineal Research|March 18, 2008
C-terminal domains within human MT1 and MT2 melatonin receptors are involved in internalization processesShalini Sethi, Wendy Adams, John Pollock, et al.
Gynecologic Oncology Reports|April 20, 2023
Role for immunotherapy in pretreated, recurrent, metastatic squamous cell carcinoma arising from mature cystic teratomaCarson C Edwards, Steven Blaine Holloway, Shalini Sethi, et al.
Journal of Medicinal Chemistry|February 6, 2009
2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonistsDarius P Zlotos, Mohamed I Attia, Justin Julius, et al.
Clinical Obstetrics and Gynecology|December 18, 2024
Placental InfectionsPoonam Khullar, Jane Date Hon, Shalini Sethi, et al.
Bioorganic & Medicinal Chemistry|May 29, 2009
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligandsChristian Markl, Mohamed I Attia, Justin Julius, et al.
Archiv Der Pharmazie|September 3, 2011
N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivityChristian Markl, William P Clafshenkel, Mohamed I Attia, et al.
Journal of Pineal Research|July 15, 2010
Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathwaysShalini Sethi, Nicholas M Radio, Mary P Kotlarczyk, et al.
Frontiers in Oncology|July 30, 2019
Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast CancerBalasunder R Dodda, Corry D Bondi, Mahmud Hasan, et al.
Journal of Pineal Research|May 30, 2012
Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female micePaula A Witt-Enderby, John P Slater, Nakpangi A Johnson, et al.
Pageof 1